ISR Reports: Covance Receives Top Ratings in Phase IV Benchmarking Study

Informing the pharmaceutical and biotech industry. Cary, N.C. – September  18, 2012 – Industry Standard Research (ISR) today announced the availability of their newest CRO Benchmarking report, 2012 CRO Quality Benchmarking – Phase IV Service Providers, which provides service quality profiles for 10 Phase IV CROs. “Covance received the highest marks across a number of … Continued

ISR Adds Biosimilar Recruitment to Growing Library of Biosimliar, Recruitment Reports

Informing the pharmaceutical and biotech industry Cary, N.C. – September 11, 2012 – Industry Standard Research (ISR) today announced the availability of a new report titled “Improving Patient Recruitment in Biosimilar Trials,” which examines patient and site recruitment in Biosimilar clinical trials. “Teva’s use of a Biologics License Application (BLA) for their regulatory submission and … Continued

Selection of Phase I Service Providers

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Selection of Phase I Service Providers” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Selection-of-Phase-I-Service-Providers/ArticleStandard/Article/detail/788581

Optimizing Investigator Fees

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Optimizing Investigator Fees” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/Optimizing-Investigator-Fees/ArticleStandard/Article/detail/800011 I’m not sure if it’s just me, but we still have some work to do on the automatically generated e-mails. I’ve provided DETAILED and SPECIFIC instructions I’d like to see … Continued

ISR CUSTOMERS